Online citations, reference lists, and bibliographies.
← Back to Search

Intranasal Immunisation Of Mice Against Streptococcus Equi Using Positively Charged Nanoparticulate Carrier Systems.

L. Figueiredo, A. Cadete, L. Gonçalves, M. L. Corvo, A. Almeida
Published 2012 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In order to potentiate a strong immune response after mucosal vaccination with a low immunogenic S. equi enzymatic extract, two positively charged particulate delivery systems (liposomes and nanoparticles) were created. Positively surface charged particles were expected to efficiently bind to negatively charged cell membranes and facilitate antigen uptake. Phosphatidylcholine-cholesterol-stearylamine liposomes encapsulating S. equi antigens were prepared and dimensionated to 0.22±0.01μm with a polydispersity index <0.242, zeta potential of +12±4mV and an encapsulation efficiency of 13±3% (w/w). Chitosan nanoparticles were prepared by ionotropic gelation with sodium tripolyphosphate, presenting a particle size of 0.17±0.01μm with polydispersity index <0.362, zeta potential of +23±8mV and an encapsulation efficiency of 53±6% (w/w). Both encapsulation methods were recognised as innocuous once antigens structure remained intact after incorporation as assessed by SDS-PAGE. Intranasal immunisation of mice with both formulations successfully elicited mucosal, humoral and cellular immune responses. Mucosal stimulation was confirmed by increased sIgA levels in the lungs, being the chitosan nanoparticles more successful in this achievement probably due to their different mucoadhesive properties. Both formulations share the ability to induce Th1-mediated immune responses characterised by IFN-γ production and high IgG2a antibody titers as well as a Th2 immune response characterised mainly by IL-4 production and IgG1 antibodies.
This paper references
10.1016/j.addr.2008.09.005
Nanoparticles for nasal vaccination.
N. Csaba (2009)
10.1016/0003-2697(75)90363-2
Lowry determination of protein in the presence of Triton X-100.
C. Wang (1975)
10.1016/j.ejpb.2008.09.028
Mucoadhesive polymeric platforms for controlled drug delivery.
G. Andrews (2009)
10.1016/j.ejps.2011.09.018
Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
A. Cadete (2012)
10.1016/j.colsurfb.2009.07.024
Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.
Mohamadreza Amin (2009)
10.1128/IAI.72.6.3228-3236.2004
Recombinant Streptococcus equi Proteins Protect Mice in Challenge Experiments and Induce Immune Response in Horses
M. Flock (2004)
10.1517/17425247.2010.488687
Liposomes as delivery systems for nasal vaccination: strategies and outcomes
B. Heurtault (2010)
10.1099/jmm.0.028233-0
Streptococcus equi: a pathogen restricted to one host.
A. Waller (2011)
10.1016/S0264-410X(00)00019-0
Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses.
M. Baca-Estrada (2000)
10.1016/S1773-2247(10)50006-6
Progress in chitosan-based vaccine delivery systems
Farid Esmaeili (2010)
10.1016/J.VACCINE.2003.11.008
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition.
C. Foged (2004)
10.1586/erv.10.89
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
M. Oyewumi (2010)
10.1007/978-1-4419-0200-9_10
Liposome-Based Mucoadhesive Formulations for Oral Delivery of Macromolecules
Pornsak Sriamornsak (2009)
10.1053/J.CTEP.2006.03.016
Streptococcus equi subsp. equi (Strangles) Infection
S. D. Taylor (2006)
10.1016/J.VACCINE.2006.02.016
Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse.
M. Flock (2006)
10.1016/J.VACCINE.2005.12.017
A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
A. Joseph (2006)
10.1016/J.EJPB.2006.04.007
Microencapsulation of Streptococcus equi antigens in biodegradable microspheres and preliminary immunisation studies.
Ana Azevedo (2006)
10.1016/J.VACCINE.2007.02.040
Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi.
J. Timoney (2007)
10.1016/j.vaccine.2008.05.074
Streptococcus equi antigens adsorbed onto surface modified poly-epsilon-caprolactone microspheres induce humoral and cellular specific immune responses.
H. Florindo (2008)
10.1016/j.biomaterials.2008.10.035
The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.
H. Florindo (2009)
10.1016/J.VACCINE.2007.09.042
Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
G. B. Patel (2007)
10.1016/j.biomaterials.2009.05.045
Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres.
Helena F. Florindo (2009)
10.1517/17425247.2011.558081
Liposomal vaccine delivery systems
M. Henriksen-Lacey (2011)
10.1016/S0264-410X(96)00099-0
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.
D. Nixon (1996)
10.1016/j.vaccine.2008.02.058
Surface modified liposomes for nasal delivery of DNA vaccine.
K. Khatri (2008)
10.1016/j.vaccine.2009.07.012
Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response.
M. Brgles (2009)
10.1016/S0169-409X(97)00066-5
Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption.
Huang (1998)
10.1136/vr.147.20.563
Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi
A. Jacobs (2000)
10.1002/jps.21493
Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
S. Sharma (2009)
10.1016/S0168-3659(99)00097-8
Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins.
T. Nakanishi (1999)
10.1007/BF02531316
Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots
G. Rouser (2006)
10.1016/S1773-2247(10)50044-3
From single-dose vaccine delivery systems to nanovaccines
Sara Vicente (2010)
10.1016/S0264-410X(00)00386-8
Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine.
B. Guy (2001)
10.2174/187221107779814140
Nanocarriers for systemic and mucosal vaccine delivery.
Aliasgar Shahiwala (2007)
10.1038/nri2868
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
M. Bachmann (2010)
10.1371/journal.ppat.1000584
Getting to Grips with Strangles: An Effective Multi-Component Recombinant Vaccine for the Protection of Horses from Streptococcus equi Infection
B. Guss (2009)
10.1016/S0168-3659(01)00412-6
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L. Thiele (2001)
10.1586/erv.09.47
Chitosan-based systems for the delivery of vaccine antigens
H. C. Arca (2009)
10.1016/j.biomaterials.2009.06.046
Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens.
Chwei-Jang Chiou (2009)
10.1016/j.vaccine.2008.12.004
New approach on the development of a mucosal vaccine against strangles: Systemic and mucosal immune responses in a mouse model.
H. Florindo (2009)
10.1016/S0005-2736(02)00457-1
Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis.
M. Luísa Corvo (2002)
10.1016/S1286-4579(02)01565-4
The molecular basis of Streptococcus equi infection and disease.
D. J. Harrington (2002)
10.1080/09687860600790537
Immunostimulation of dendritic cells by cationic liposomes
D. P. Vangasseri (2006)
10.1016/J.TVJL.2006.05.011
Getting a grip on strangles: recent progress towards improved diagnostics and vaccines.
A. Waller (2007)
10.1099/00221287-144-4-993
Affinity purification and characterization of a fibrinogen-binding protein complex which protects mice against lethal challenge with Streptococcus equi subsp. equi.
M. Meehan (1998)
10.1006/MPAT.1999.0290
Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice.
N. Chanter (1999)



This paper is referenced by
10.2217/nnm-2017-0015
Recent developments in nanocarrier-aided mucosal vaccination.
Olga Kammona (2017)
Novel antibiotic-loaded orthopaedic bone cements: insights on drug release profiles and biocompatibility
Sofia P. M. Silva (2015)
Identificación de subpoblaciones de macrófagos y linfocitos T en pulmones de pacientes fallecidos por influenza A H1N1
R. Ramírez (2014)
10.3389/fimmu.2018.00934
Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
S. Dhakal (2018)
10.3109/00016489.2014.918278
Amphiphilic γ-PGA nanoparticles administered on rat middle ear mucosa produce adjuvant-like immunostimulation in vivo
Johan Nilsson (2014)
10.1007/978-94-017-8896-0_7
Mucus as Physiological Barrier to Intracellular Delivery
Eleonore Fröhlich (2014)
10.1177/2051013614541440
Liposomes as vaccine delivery systems: a review of the recent advances
R. Schwendener (2014)
Novel particulate BCG-loaded delivery system for mucosal immunization against tuberculosis
L. A. Caetano (2016)
10.1109/ENBENG.2013.6518391
Chitosan-alginate microparticulate delivery system for an alternative route of administration of BCG vaccine
Liliana Aranha Caetano (2013)
10.1007/978-1-4939-0820-2
Reproductive Sciences in Animal Conservation
W. Holt (2014)
10.4161/hv.26136
Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses
V. Joshi (2013)
10.1080/02652048.2017.1316325
BCG-loaded chitosan microparticles: interaction with macrophages and preliminary in vivo studies
Liliana Aranha Caetano (2017)
Melhoramento de uma vacina multi-antigénica contra a Helicobacter pylori
Faculdade de Engenharia (2014)
10.1007/978-1-4939-0820-2_18
Fertility control in wildlife: review of current status, including novel and future technologies.
Deborah A. Garside (2014)
10.1016/j.copbio.2013.11.005
Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale.
Joseph A. Rosenthal (2014)
10.1016/j.biotechadv.2015.05.010
Nanoengineering of vaccines using natural polysaccharides
A. S. Cordeiro (2015)
10.1016/j.ijbiomac.2020.09.042
Chitosan: Structural modification, biological activity and application.
W. Wang (2020)
10.13345/j.cjb.150405
[Prokaryotic expression and immunogenicity of IgG-binding protein of Streptococcus equi subspecies equi].
Jungao Shao (2016)
Evaluation of a new vaccine based on pDNA and recombinant protein against Helicobacter pylori
Maria Rita Rebocho Lopes do Amaral (2012)
10.3389/fimmu.2018.00155
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases
R. Nisini (2018)
10.1016/J.PROGPOLYMSCI.2016.06.002
Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications
Loïc Bugnicourt (2016)
10.1208/s12249-013-0058-7
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
Chompoonuch Sawaengsak (2013)
10.3390/md14050090
Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation
Liliana Aranha Caetano (2016)
10.3389/fimmu.2018.02224
Nanoparticle Vaccines Against Infectious Diseases
R. Pati (2018)
Semantic Scholar Logo Some data provided by SemanticScholar